Emeprid 5 mg/ml solution for injection for dogs and cats

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

Metoclopramide hydrochloride

Available from:

Ceva Santé Animale

ATC code:

QA03FA01

INN (International Name):

Metoclopramide hydrochloride

Dosage:

5 milligram(s)/millilitre

Pharmaceutical form:

Solution for injection

Prescription type:

POM: Prescription Only Medicine as defined in relevant national legislation

Therapeutic group:

Cats, Dogs

Therapeutic area:

metoclopramide

Therapeutic indications:

Miscellaneous

Authorization status:

Authorised

Authorization date:

2010-12-10

Summary of Product characteristics

1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Emeprid 5 mg/ml solution for injection for dogs and cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Metoclopramide (as hydrochloride)
............................................................ 4.457 mg
equivalent to metoclopramide hydrochloride
.................................................... 5 mg
EXCIPIENTS:
QUALITATIVE
COMPOSITION OF EXCIPIENTS AND
OTHER CONSTITUENTS
QUANTITATIVE COMPOSITION IF THAT INFORMATION
IS ESSENTIAL FOR PROPER ADMINISTRATION OF THE
VETERINARY MEDICINAL PRODUCT
Metacresol
2 mg
Sodium chloride
Water for injections
Clear, colourless solution.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Dogs and cats.
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
Symptomatic treatment of vomiting and reduced gastro-intestinal
motility associated with gastritis, pyloric
spasm, chronic nephritis and digestive intolerance to some drugs.
3.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
Do not use in cases of gastro-intestinal perforation or obstruction.
Do not use in the case of gastro-intestinal haemorrhage.
3.4
SPECIAL WARNINGS
None.
3.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR SAFE USE IN THE TARGET SPECIES
The dosage must be adapted in animals with renal or hepatic
insufficiency (due to an increase in the risk of
side effects). Avoid administration to animals with epilepsy. The
dosage should be carefully observed,
especially in cats and small breed dogs.
Following prolonged vomiting, consideration should be given to fluid
and electrolyte replacement therapy.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO
ANIMALS
Wash hands after administration to the animal.
In case of accidental self-injection, seek medical advice immediately
and show the package leaflet or the
label to the physician.
In case of accidental exposure by spillage onto the skin or eyes, wash
immediately with abundant water. If
advers